Clinical Trials Logo

Clinical Trial Summary

Myelomeningocele is a malformation with high incidence, and it consists in a neural tube defect. Fetal intrauterine surgery is an alternative for correction, and it improves the prognosis of the fetus, but has an increased risk of maternal complications and premature labor, as it can occur due to uterine stimulation. It is therefore essential that tocolysis is performed before, during and after surgery, and the most commonly used tocolytics are terbutaline and atosiban. Terbutaline has no specificity and may have several adverse effects such as maternal acidosis.


Clinical Trial Description

The objective of the study was to evaluate maternal blood gas alterations among cases that used atosiban tocolytic agent and cases with terbutaline in in utero repair of myelomeningocele. It consists of a retrospective cohort study. It included 25 patients, who were divided into two groups, depending on which agent they received as main tocolytic agent during the intrauterine fetal myelomeningocele repair: terbutalineor atosiban. The primary outcome was maternal arterial pH at the end of surgery. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04468568
Study type Observational
Source University of Sao Paulo General Hospital
Contact
Status Completed
Phase
Start date October 1, 2017
Completion date April 1, 2022

See also
  Status Clinical Trial Phase
Recruiting NCT06042140 - Cryopreserved Human Umbilical Cord as a Meningeal Patch in Fetoscopic Spina Bifida Repair N/A
Recruiting NCT03562286 - Open Spina Bifida Fetoscopic Repair Project N/A
Recruiting NCT04362592 - In-Utero Endoscopic Correction of Spina Bifida N/A
Recruiting NCT03856034 - Laparotomy Versus Percutaneous Endoscopic Correction of Myelomeningocele N/A
Active, not recruiting NCT03936322 - Minimally Invasive Fetoscopic Regenerative Repair of Spina Bifida - A Pilot Study N/A
Not yet recruiting NCT06405698 - Role of Perforator Flaps in Back Defects Reconstruction N/A
Active, not recruiting NCT00175123 - Effect of Botulinum Toxin in Neurogenic Bladders in Children With Myelomeningocele Phase 4
Completed NCT02390895 - Prenatal Endoscopic Repair of Fetal Spina Bifida N/A
Active, not recruiting NCT03090633 - Fetoscopic Repair of Isolated Fetal Spina Bifida N/A
Not yet recruiting NCT03088761 - Cuff Pressure in Infants N/A
Active, not recruiting NCT04484441 - Maternal-fetal Immune Responses to Fetal Surgery
Recruiting NCT04738539 - Efficacy of Contrast Enhanced Voiding Urosonography for Urodynamic Studies
Recruiting NCT04652908 - Cellular Therapy for In Utero Repair of Myelomeningocele - The CuRe Trial Phase 1/Phase 2
Terminated NCT02493062 - Evaluation of Hysterotomy Site After Open Fetal Surgery N/A
Completed NCT03550898 - Can Dynamic Ultrasonography Replace Urodynamics in Follow-up of Patients With Myelomeningocele N/A
Active, not recruiting NCT04251806 - Sleep-disordered Breathing in Infants With Myelomeningocele
Terminated NCT02509377 - Fetal Myelomeningocele Repair With Maternal BMI Between 35.0 and 40.0 N/A
Recruiting NCT03788122 - Fetal Surgery Interview Study: Parental Perceptions of Fetal Surgery N/A
Completed NCT02664207 - Extended Criteria For Fetal Myelomeningocele Repair N/A
Recruiting NCT03315637 - Fetal Endoscopic Surgery for Spina Bifida N/A